Browsing Tag
peripheral artery disease
5 posts
Semaglutide shows significant vascular benefits in PAD patients with type 2 diabetes, STRIDE trial confirms
Semaglutide improves walking capacity and reduces disease progression in PAD patients with type 2 diabetes, STRIDE trial results reveal at ADA 2025.
Sensome’s Clotild clot-sensing guidewire shows promise in peripheral artery disease treatment studies
A breakthrough innovation in the treatment of peripheral artery disease (PAD) could soon transform clinical practice, offering clinicians…
CoreRx to formulate and manufacture JanOne’s peripheral artery disease candidate
JanOne has signed a manufacturing agreement with cGMP contract manufacturer CoreRx for the clinical formulation and manufacturing of…
Amarin bags Vascepa FDA approval for reducing cardiovascular risk
Vascepa FDA approval : New Jersey-based Amarin has secured approval from the US Food and Drug Administration (FDA)…
Symic Bio initiates SB-030 Phase 1/2a study in peripheral artery disease
Symic Bio, a biopharmaceutical company based in California specializing in matrix biology, is set to commence a phase…